在老年患者的Helicobacter pylori根除治疗
Paulius Jonaitis1, Juozas Kupcinskas2, Javier P Gisbert3
1Department of Gastroenterology, Lithuanian University of Health Sciences, Eiveniu Street 2, 50161, Kaunas, Lithuania. pjonaitis95@gmail.com.
Drugs & aging
|February 10, 2024
概括
建议对老年人进行Helicobacter pylori的根除,提供显著的好处. 治疗是安全和有效的,四重疗法达到90%以上的成功率,符合一般成人指南.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 老年病的医生 老年病的医生
背景情况:
- 杆菌 (H. pylori) 是胃炎,胃潰瘍和胃癌的主要原因.
- 老龄化人口的H. pylori患病率较高,但对老年人治疗的研究是有限的.
- 与年龄相关的因素可能会影响H. pylori治疗的有效性和安全性.
研究的目的:
- 审查有关H. pylori感染和老年患者治疗的当前文献.
- 评估H. pylori根除在老龄化人口中的好处和安全性.
- 为老年人提供基于证据的H. pylori治疗建议.
主要方法:
- 对老年患者的H. pylori最近的出版物和研究进行了全面的审查.
- 对H. pylori根除治疗指南和安全数据的分析.
- 对老年人根除有效性和不良事件的评估.
主要成果:
- 根除 H. pylori 在老年人中提供了胃肠道和肠外的好处.
- 治疗通常是安全的,有轻微的,短期的不良事件和良好的遵守.
- 四重疗法 (基于比斯木和非比斯木) 达到90%以上的根除效率.
结论:
- 在老年患者中,不论年龄,除了绝症患者,都应追求H. pylori的根除.
- 对于H. pylori治疗的标准成人指南适用于老年人群.
- 优化治疗包括四重疗法,更长的持续时间,高剂量的PPI和受敏感性引导的方法.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
403
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
403
01:26Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
01:23Gastritis III: Clinical Manifestations and Management
251
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
251
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
122
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
122
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
431
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
431
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
484
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
484